Altre lingue Reneo Pharmaceuticals, Inc.

Azioni

RPHM

US75974E1038

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:01 03/05/2024			Variaz. 5gg	Var. 1 gen.
1,74 ^USD	+0,58%		+4,19%	+8,75%

28/03	Reneo Pharmaceuticals, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
2023	RENEO PHARMACEUTICALS, INC. : Ladenburg Thalmann abbassa il rating a Neutral	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update	28/03
North American Morning Briefing : Tech in Focus on -2-	25/03
Wall Street ouvre stable en l'absence de nouveaux catalyseurs	27/12
Concentra Biosciences, LLC submitted a non-binding proposal to acquire Reneo Pharmaceuticals, Inc. for $60 million.	26/12
North American Morning Briefing : Stock Futures -2-	18/12
Reneo Pharmaceuticals, Inc.(NasdaqGM:RPHM) added to NASDAQ Biotechnology Index	18/12
Sector Update: Health Care Stocks Slipping Late Afternoon	14/12
Top Midday Decliners	14/12
Sector Update: Health Care Stocks Ease Thursday Afternoon	14/12
Reneo Pharmaceuticals Says Pivotal Study of Mavodelpar Fails to Meet Primary, Secondary Endpoints; Shares Plunge	14/12
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	14/12
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	14/12
Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results	13/11
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	02/11
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	02/11
Women in Stem with Ashley Hall	31/10/23
Reneo Pharmaceuticals, Inc. announces an Equity Buyback for 576,443 shares, for $4.4 million.	30/10/23
Reneo Pharmaceuticals, Inc. authorizes a Buyback Plan.	30/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Reneo Pharmaceuticals, Inc.

Azioni

RPHM

US75974E1038

Altre lingue

Filtri